PCSK9 Archives - Cardiovascular News

ACC 2017: Positive final results from ORION-1 phase II study of inclisiran

21st March 2017

The Medicines Company and...

AHA 2016: Two thirds of patients experience plaque regression with the PCSK9 inhibitor evolocumab

16th November 2016

Amgen has announced t...

Positive top-line results from phase 3 GLAGOV imaging study of evolocumab

21st September 2016

The Phase 3 GLAGOV (G...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy